Envista (NYSE:NVST) Announces Quarterly Earnings Results

Envista (NYSE:NVST) released its quarterly earnings data on Wednesday. The company reported $0.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.31 by $0.05, FiscalAI reports. The company had revenue of $705.50 million during the quarter, compared to analysts’ expectations of $680.04 million. Envista had a return on equity of 7.09% and a net margin of 2.41%.The business’s revenue was up 14.4% on a year-over-year basis. During the same period last year, the firm posted $0.24 earnings per share. Envista updated its FY 2026 guidance to 1.350-1.450 EPS.

Here are the key takeaways from Envista’s conference call:

• Envista reported a strong Q1 with core sales up 9.5% (≈4% normalized excluding extra billing days and Spark deferral), adjusted EBITDA +25% and adjusted EPS +50%, and management reaffirmed full‑year 2026 guidance.
• Leadership expanded shareholder returns, authorizing an incremental $300 million buyback (1.6M shares purchased in Q1) while maintaining a conservative balance sheet with net debt <1x adjusted EBITDA.
• Continued investment and execution — double‑digit increases in sales & marketing and R&D, plus Envista Business System gains — drove a 100 bps gross margin uplift and 120 bps adjusted EBITDA margin improvement.
• Regional and policy risks pose near‑term headwinds, notably VBP-related channel destocking in China causing double‑digit implant declines there, plus geopolitical uncertainty in the Middle East and a looming Q4 billing‑day timing headwind.
• Cash and cost dynamics are mixed — Q1 free cash flow was a seasonal –$16M as CapEx rose for new facilities and tariffs added about $11M of costs, but management still expects roughly 100% free cash flow conversion for 2026.

Envista Price Performance

NVST traded down $0.03 on Friday, hitting $24.27. 4,873,624 shares of the stock were exchanged, compared to its average volume of 2,875,691. The firm has a market capitalization of $3.95 billion, a price-to-earnings ratio of 59.18, a PEG ratio of 1.85 and a beta of 0.92. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.38 and a quick ratio of 2.04. Envista has a 12 month low of $16.41 and a 12 month high of $30.42. The business has a 50-day moving average of $26.53 and a two-hundred day moving average of $24.06.

More Envista News

Here are the key news stories impacting Envista this week:

• Positive Sentiment: Envista reported better-than-expected Q1 2026 results, with EPS of $0.36 versus the $0.31 consensus and revenue of $705.5 million versus $680.0 million expected, suggesting solid demand and execution. Envista (NYSE:NVST) Posts Better-Than-Expected Sales In Q1 CY2026
• Positive Sentiment: Management’s earnings transcript and presentation are likely reinforcing confidence in the turnaround and highlighting new growth drivers, which can support the stock if investors see improving fundamentals. Envista (NVST) Q1 2026 Earnings Transcript
• Positive Sentiment: Robert W. Baird raised its price target on Envista to $31 from $30 and kept an outperform rating, while JPMorgan lifted its target to $29 from $26, signaling improved analyst sentiment after the earnings beat.
• Positive Sentiment: Zacks highlighted Envista as a top long-term growth stock, which may help reinforce the market’s view that the company has attractive longer-term earnings potential. Why Envista (NVST) is a Top Growth Stock for the Long-Term
• Neutral Sentiment: Additional coverage on the Q1 earnings snapshot and key metrics is mostly informational, but it keeps the company in focus as investors assess whether the earnings beat is sustainable. Envista: Q1 Earnings Snapshot
• Neutral Sentiment: The stock still faces some caution because JPMorgan’s rating remained neutral despite the higher target, indicating analysts see upside but not a clear near-term rerating.

Insider Buying and Selling at Envista

In related news, SVP Mischa Reis sold 9,675 shares of the stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $30.00, for a total transaction of $290,250.00. Following the sale, the senior vice president owned 32,382 shares in the company, valued at approximately $971,460. This trade represents a 23.00% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 0.99% of the company’s stock.

Hedge Funds Weigh In On Envista

Hedge funds and other institutional investors have recently modified their holdings of the business. Van ECK Associates Corp lifted its holdings in shares of Envista by 51.7% in the fourth quarter. Van ECK Associates Corp now owns 10,705 shares of the company’s stock worth $232,000 after acquiring an additional 3,647 shares during the last quarter. Entropy Technologies LP acquired a new position in shares of Envista during the fourth quarter worth $224,000. Lazard Asset Management LLC bought a new position in shares of Envista in the 4th quarter valued at $213,000. Maryland State Retirement & Pension System acquired a new position in Envista in the 4th quarter worth about $212,000. Finally, Virtus Advisers LLC bought a new position in Envista in the third quarter valued at about $205,000.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the company. Morgan Stanley increased their target price on Envista from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Friday, April 24th. Wells Fargo & Company upped their price objective on Envista from $21.00 to $26.00 and gave the company an “equal weight” rating in a report on Friday, February 6th. Citigroup initiated coverage on Envista in a report on Wednesday, April 15th. They set a “neutral” rating and a $29.00 target price for the company. Mizuho raised their price target on shares of Envista from $24.00 to $27.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 10th. Finally, Leerink Partners set a $35.00 price objective on shares of Envista and gave the company an “outperform” rating in a report on Friday, February 6th. Six investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $28.83.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.